Announcement on Convening the Q3 2024 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Earlier from InventisBio
- Announcement on Asset Purchase and Related Party Transactions
- Announcement on the Vesting Results and Stock Listing of the 1st Vesting Period of Reserved Granted Part in 2022 Restricted Stock Incentive Plan
- Announcement on Change of Sponsor Representative for Continuous Supervision
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024
- Announcement on Resolution of the 5th Meeting of the 2nd Board of Directors in 2024
Later from InventisBio
- Report for Q3 2024
- Announcement on Release of Pledge of Some Shares by Shareholders Holding More Than 5%
- Announcement on Voluntary Announcement of Results of the Phase II Clinical Trial of D-2570
- Announcement on Share Reduction Plan for Shareholders
- Announcement on Resolutions of the 1st Meeting of the 2nd Board of Supervisors in 2025
Follow InventisBio into a list and get an email when it puts out news.
Follow InventisBio